Literature DB >> 11350951

Transcriptional repression by p53 through direct binding to a novel DNA element.

R A Johnson1, T A Ince, K W Scotto.   

Abstract

The tumor suppressor protein p53 has been well documented as a transcriptional activator involved in the regulation of a number of critical genes involved in the cell cycle, response to DNA damage, and apoptosis. Activation by p53 requires the interaction of the protein with a consensus binding site consisting of two half-sites, each comprising two copies of the sequence PuPuPuC(A/T) arranged head-to-head and separated by 0-13 base pairs. In addition to activation, p53 has been shown to be a potent repressor of transcription. However, the basis for p53-mediated repression is not well understood and has been proposed to occur indirectly through interactions with other promoter-bound transcription factors. In the present study, we show that p53 can repress transcription directly by binding to a novel head-to-tail (HT) site within the MDR1 promoter. A mutation that disrupted p53 binding to the MDR1 HT site blocked p53-mediated repression of the MDR1 promoter in transfection assays. Replacement of the HT site with a head-to-head (HH) site converted the activity of p53 from repression to activation, indicating that simple recruitment of p53 to the promoter is not sufficient for repression and that the orientation of the binding element determines the fate of p53-regulated promoters.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11350951     DOI: 10.1074/jbc.C100121200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Transcriptional repression by p53 promotes a Bcl-2-insensitive and mitochondria-independent pathway of apoptosis.

Authors:  Nelly Godefroy; Sylvina Bouleau; Gaëtan Gruel; Flore Renaud; Vincent Rincheval; Bernard Mignotte; Diana Tronik-Le Roux; Jean-Luc Vayssière
Journal:  Nucleic Acids Res       Date:  2004-08-23       Impact factor: 16.971

2.  HOXA5 regulates hMLH1 expression in breast cancer cells.

Authors:  Sai Duriseti; Paul T Winnard; Yelena Mironchik; Farhad Vesuna; Ana Raman; Venu Raman
Journal:  Neoplasia       Date:  2006-04       Impact factor: 5.715

3.  SAK, a new polo-like kinase, is transcriptionally repressed by p53 and induces apoptosis upon RNAi silencing.

Authors:  Jun Li; Mingjia Tan; Ling Li; Deepika Pamarthy; Theodore S Lawrence; Yi Sun
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 4.  Transcriptional regulation by p53.

Authors:  Rachel Beckerman; Carol Prives
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-28       Impact factor: 10.005

Review 5.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

6.  Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 7.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

8.  DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function.

Authors:  A Vilgelm; J X Wei; M B Piazuelo; M K Washington; V Prassolov; W El-Rifai; A Zaika
Journal:  Oncogene       Date:  2007-10-22       Impact factor: 9.867

9.  Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.

Authors:  Ying Jin; Wenquan Hu; Tong Liu; Ujala Rana; Irene Aguilera-Barrantes; Amanda Kong; Suresh N Kumar; Bei Wang; Pin Gao; Xiang Wang; Yajun Duan; Aiping Shi; Dong Song; Ming Yang; Sijie Li; Bing Han; Gang Zhao; Zhimin Fan; Qing Robert Miao
Journal:  Cancer Lett       Date:  2018-02-02       Impact factor: 8.679

10.  Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf.

Authors:  Xiaohua Su; Min Soon Cho; Young-Jin Gi; Bernard A Ayanga; Charles J Sherr; Elsa R Flores
Journal:  EMBO J       Date:  2009-06-04       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.